Edition:
United States

Insider Trading: Sangamo Therapeutics Inc (SGMO.O)

SGMO.O on Nasdaq

7.25USD
26 May 2017
Change (% chg)

$-0.55 (-7.05%)
Prev Close
$7.80
Open
$7.80
Day's High
$7.90
Day's Low
$7.25
Volume
1,247,466
Avg. Vol
1,038,925
52-wk High
$8.60
52-wk Low
$2.65

All Insider Trades
Trading Date Name Title Type Shares Traded Price
11 May 2017

Herberts (Curt A III)

Officer Sell 2,000 $8.50
10 May 2017

Herberts (Curt A III)

Officer Sell 639 $6.50
11 Dec 2016

Herberts (Curt A III)

Chairman of the Board Sell 4,852 $3.05
11 Dec 2016

Lanphier (Edward O II)

Director Gift 30,000 $0.00
12 Jun 2016

Lanphier (Edward O II)

Director Sell 15,658 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 21,741 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 16,107 $6.23
12 Jun 2016

Lanphier (Edward O II)

Director Sell 9,395 $6.23
6 Jun 2016

Lanphier (Edward O II)

Director Gift 50,000 $0.00
10 Mar 2016

Lanphier (Edward O II)

Director Gift 8,000 $0.00
11 Dec 2015

Nichol (Geoffrey M)

Officer Sell 4,384 $8.68
11 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 6,087 $8.68
11 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 13,778 $3.05
11 Dec 2015

Ando (Dale Genji)

Officer Sell 4,000 $8.68
11 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 13,045 $8.68
10 Dec 2015

Nichol (Geoffrey M)

Officer Sell 4,697 $8.68
10 Dec 2015

Ando (Dale Genji)

Officer Sell 4,348 $8.68
10 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Sell 21,741 $8.68
10 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 6,522 $8.68
7 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Buy 37,500 $0.00
7 Dec 2015

Ando (Dale Genji)

Officer Buy 25,000 $0.00
7 Dec 2015

Nichol (Geoffrey M)

Officer Buy 37,500 $0.00
7 Dec 2015

Lanphier (Edward O II)

Chief Executive Officer Buy 125,000 $0.00
6 Dec 2015

Wolff (Henry Ward)

Chief Financial Officer Sell 7,060 $9.69

Institutional Holders

% Shares Owned: 58.91%
# of Holders: 167
Total Shares Held: 42,381,606
3 Mo. Net Change: 294,529
# New Positions: 19
# Closed Positions: 20
# Increased Positions: 57
# Reduced Positions: 70
# Net Buyers: -13

Officers & Directors

Name Age Since Current Position

Edward Lanphier

58 2016 Non-Executive Chairman of the Board

Alexander Macrae

2016 President, Chief Executive Officer, Director

Kathy Yi

45 2017 Chief Financial Officer, Senior Vice President

Dale Ando

60 2004 Vice President - Therapeutic Development, Chief Medical Officer

H. Stewart Parker

59 2014 Director

William Ringo

71 2016 Director

Stephen Dilly

55 2010 Independent Director

John Larson

81 1996 Independent Director

Steven Mento

63 2005 Independent Director

Saira Ramasastry

39 2012 Independent Director

Elizabeth Wolffe

IR Contact Officer, Corporate Communications